ONC-201 Uses, Dosage, Side Effects and more
ONC-201 is under investigation in clinical trial NCT03394027 (ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma).
| Trade Name | ONC-201 |
| Generic | ONC-201 |
| Type | |
| Formula | C24H26N4O |
| Weight | Average: 386.499 Monoisotopic: 386.210661473 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
